Study to test the effectiveness of a simple, wearable heart rhythm monitor for patients in that crucial first month after TAVI. This innovative approach offers a practical and cost-effective way to detect delayed heart block earlier, potentially preventing serious complications and improving patient outcomes.
Professor Rasmussen and his team have been looking at repurposing Beta3 Adrenergic receptor agonists, a drug already FDA-approved for the treatment of overactive bladders, as a treatment that could offer improved care of ‘high-risk’ pregnancies with pre-eclampsia and/or IUGR. It’s hoped that this will enhance future maternal cardiovascular health.
Heart patches made of personalised ‘bio-inks’ to help regenerate parts of the heart that have died following a severe heart attack.
Dr Chris Roche, a cardiac surgical trainee funded by HROz since 2019, has brought surgical skills and insights to the research team supervised by Dr Carmine Gentile – a bioprinting expert working towards producing heart patches made of special ‘bio-ink’. Dr Roche has been working on a spin-off project to his PhD where he has designed and prototyped